Contact
Please use this form to send email to PR contact of this press release:
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
TO:
Please use this form to send email to PR contact of this press release:
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
TO: